Printer-friendly versionPrinter-friendly version

Burden and Prevention of Viral Hepatitis in Turkey

Istanbul, Turkey, November 13-14, 2009

Thursday, November 12, 2009

Session 1  Opening and objectives
Chair:  Selim Badur, Nedret Emiroglu

  • 09.00 - 09.25
  • Welcome and opening
  • Introduction of the participants
  • Introduction of the VHPB:    646 Kb(.pdf) prepared by  P. Van Damme presented by N. Emrioglu
  • Objectives of the meeting:
    • Provide an overview of surveillance systems for infectious diseases;
    • Review the epidemiological situation on viral hepatitis;
    • Give an overview of the current prevention and control measures on viral hepatitis;
    • Discuss the progress achieved in hepatitis prevention 10 years after the introduction of Universal Hepatitis B vaccination;
    • Review the possible implementation of new prevention strategies, control measures and monitoring systems;
    • Discuss the successes, problems and barriers to overcome, and the way forward
  • Review of the meeting programme
  • Pre-meeting document   311KB (.pdf)

Session 2 Overview of health care system and communicable disease prevention and control in Turkey
Chair:   Selim Badur, Nedret Emiroglu

09.30 – 10.30
Communicable diseases surveillance systems and immunization service delivery  881Kb (.pdf)
Dr Ümit Özdemirer

10.30 – 10.45 Coffee Break

Session 3 Epidemiology of viral hepatitis in Turkey
Chair: Nicole Guérin, Mark Kane

10.45 – 11.05
The epidemiological situation of hepatitis B and D in Turkey  707Kb (.pdf)
Arzu Sayiner

11.05 – 11.25
The hepatitis A vaccination in Turkey: targeted versus universal  1,2Mb (.pdf)
Mehmet Ceyhan

11.25 – 11.45
The epidemiological situation of hepatitis C in Turkey    1,1Mb (.pdf)
Selda Erensoy

11.45 – 12.05 Discussion

12.05 – 13.30 Lunch

Chair: Heléne Norder, Wolfgang Jilg

13.30 – 13.50
Molecular epidemiology of viral hepatitis in Turkey   3,7Mb (.pdf)
Hakan Abacioglu

11.05 – 11.25
Epidemiology of chronic hepatitis and cirrhosis in Turkey  2,1Mb (.pdf)
Cihan Yurdaydin

11.25 – 11.45
Mutants problems in Turkey    1Mb (.pdf)
Ulus Akarca

14.30 – 14.50  Discussion

14.50 – 15.25  Coffee break

Session 4 Review of progress achieved in hepatitis prevention and control in Turkey
Chair: Francoise Roudot-Thoraval, Koen Van Herck

15.25 – 15.45
HBV immunization policies and lessons learnt after 10 years of implementation   2,5Mb (.pdf)
Dr Ümit Özdemirer

15.45 – 16.05
Results from the blood bank screening in Turkey  284Kb (.pdf)
Yasemin Heper 

16.05 –16.25
Approach of NGO's   934Kb (.pdf)
Nurdan Tözün  

16.25 – 16.45
Therapeutic algorithm in the treatment of chronic hepatitis in Turkey  486Kb
Yilmaz Çakaloglu

16.45 – 17.05 Discussion

17.05              End of the Day

Friday, November 13, 2009

Session 5  Different aspects of viral hepatitis in Turkey
Chair: Angela Dominguez, Daniel Lavanchy

09.00 – 09.20
Viral hepatitis and Transplantation. 1,8Mb (.pdf)
Zeki Karasu

09.20 – 09.40
Victimes of human trafficking and viral hepatitis.  888KB (pdf)
Muthar Çokar

09.40 – 10.00
Economic aspects of viral hepatitis in Turkey   874Kb (.pdf)
Levent Akin

10.00 – 10.20
Healthcare workers and viral hepatitis     479Kb (.pdf)
Bülent Deðertekin

10.20 – 10.40 Discussion

10.40 – 11.00 Coffee break

Session 6  Evaluation of viral hepatitis prevention and control measures
Chair: Johannes Hallauer, Steven Wiersma

11.00 – 11.30
Global HCV prevention and control measures: lesson learnt and opportunities  403Kb (.pdf)
Daniel Lavanchy

11.30 – 12.00
HBV prevention and control programmes in Turkey and in the European Region of WHO  671Kb (.pdf)
Nedret Emiroðlu

12.00 – 12.30
Speeding-up Hepatitis B and C control in WHO Eastern Mediterranean Region 2,8Mb (.pdf)
Ezzeddine Mohsni

12.30 – 12.40 Discussion

12.40 – 14.15 Lunch

Session 7 Conclusions of the meeting
Chair:  John Ward, Daniel Shouval

14.15 – 14.45
Presentation of the VHPB meeting conclusions   87Kb (.pdf)
D. FitzSimons
 
15.00 Close of the meeting

Tags: